Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of Oral Ketorolac for Pain Reduction in IUD Insertion
NCT06853327Phase 2Enrolling by invitation
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- May 2025
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketorolac, sponsored by University of North Carolina at Chapel Hill. Started May 2025; status: enrolling by invitation.
02
Drugs
ketorolac
Beyond the preview
Go deeper on NCT06853327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06853327.